-
Strainprint™ Technologies Ltd. And Gynica launch Next Phase of Cannabis Study to Treat Endometriosis Symptoms – Cision
Strainprint™ Technologies Ltd is pleased to launch the next stage of the much-anticipated clinical trial with Israeli based research group Gynica to develop a product formulation to treat endometriosis and its symptoms. This phase will include asking endometriosis sufferers in Canada and Israel to complete an anonymous, comprehensive custom questionnaire about how they use cannabis to treat their symptoms.
We would love for you to share with us! Please sign up and join the conversation.